METTL3 and IGF2BP1-Mediated m6A Modification of ZHX2 Promotes Tumor Property of Renal Cell Carcinoma
METTL3 and IGF2BP1-mediated m6A modification of ZHX2 promoted RCC progression. The finding suggests that ZHX2 may serve as a potential therapeutic target in RCC, providing valuable insights for future clinical interventions.
Authors
- Bangming Xiao (ORCID: https://orcid.org/0000-0002-2460-9545)
- Shide Gong
- Congbo Chen
- Hao Li (ORCID: https://orcid.org/0000-0002-9377-1706)
- Wang Li (ORCID: https://orcid.org/0000-0002-5727-9829)
- Yalan Li (ORCID: https://orcid.org/0000-0003-1569-5995)
- Yong Yang (ORCID: https://orcid.org/0000-0001-5701-046X)
- Qisheng Yao
Institutions
- Hubei University of Medicine (CN)
- Taihe Hospital (CN)
Publication Details
- Journal
- Kidney & Blood Pressure Research
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1159/000540483
- Citations
- 7
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.64